Lymphocyte counts and infection rates: Long-term fingolimod treatment in primary progressive MS

OBJECTIVE: To evaluate lymphocyte counts and incidences of infections in patients with primary progressive MS (PPMS) receiving fingolimod 0.5 mg/d or placebo over 5 years during the INFORMS study, to assess infection rates with longer-term treatment. METHODS: INFORMS was a randomized, multicenter, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Edward J., Lublin, Fred D., Wolinsky, Jerry S., Cohen, Jeffrey A., Williams, Ian M., Meng, Xiangyi, Ziehn, Marina, Kolodny, Scott, Cree, Bruce A.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745722/
https://www.ncbi.nlm.nih.gov/pubmed/31511330
http://dx.doi.org/10.1212/NXI.0000000000000614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745722/
https://www.ncbi.nlm.nih.gov/pubmed/31511330
http://dx.doi.org/10.1212/NXI.0000000000000614

Ejemplares similares